Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
22,525
+18,889
+519% +$2.08M 0.01% 663
2026
Q1
$382K Sell
3,636
-53,874
-94% -$6.33M ﹤0.01% 923
2025
Q4
$7.18M Buy
57,510
+36,517
+174% +$4.35M 0.03% 435
2025
Q3
$2.52M Sell
20,993
-1,649
-7% -$174K 0.01% 672
2025
Q2
$2.08M Sell
22,642
-69,446
-75% -$6.33M 0.01% 417
2025
Q1
$8.1M Buy
92,088
+6,933
+8% +$682K 0.04% 291
2024
Q4
$7.88M Buy
85,155
+60,974
+252% +$5.87M 0.04% 284
2024
Q3
$2.24M Buy
24,181
+18,502
+326% +$1.55M 0.01% 490
2024
Q2
$426K Sell
5,679
-5,986
-51% -$478K ﹤0.01% 770
2024
Q1
$1.01M Sell
11,665
-61,958
-84% -$4.74M 0.01% 572
2023
Q4
$5.09M Buy
+73,623
New +$4.44M 0.03% 364

Other funds holding CRH

Bridgewater Associates's CRH Position: Q2 2026 in Review

Bridgewater Associates increased its CRH (CRH) stake by 519% in Q2 2026, buying an estimated $2.08M and bringing the position to 22,525 shares worth $2.41M. The position accounts for 0.01% of the portfolio, ranked #663.

Bridgewater Associates first reported a position in CRH in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.1M in Q1 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Bridgewater Associates held 22,525 shares of CRH worth $2.41M as of Q2 2026.
  • Bridgewater Associates bought 18,889 CRH shares in Q2 2026, an estimated $2.08M.
  • CRH made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #663 holding.
  • Bridgewater Associates first reported a position in CRH in Q4 2023 and has held it in 11 quarters since.
  • Bridgewater Associates's CRH position peaked at $8.1M in Q1 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.